Intravenous immunoglobulin for Alzheimer's disease.
作者信息
Relkin N
机构信息
Department of Neurology and Brain Mind Research Institute, Weill Cornell Medical College, New York, NY, USA.
出版信息
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):27-9. doi: 10.1111/cei.12500.
Abstract
摘要
相似文献
1
Intravenous immunoglobulin for Alzheimer's disease.用于治疗阿尔茨海默病的静脉注射免疫球蛋白
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):27-9. doi: 10.1111/cei.12500.
2
Intravenous immunoglobulin for Alzheimer's disease.
Lancet Neurol. 2013 Mar;12(3):218-9. doi: 10.1016/S1474-4422(13)70015-2. Epub 2013 Jan 31.
3
Intravenous immunoglobulin and Alzheimer's disease immunotherapy.静脉注射免疫球蛋白与阿尔茨海默病免疫疗法
Curr Opin Mol Ther. 2007 Feb;9(1):79-85.
4
Intravenous immunoglobulins for Alzheimer's disease.
Lancet Neurol. 2004 Dec;3(12):704. doi: 10.1016/S1474-4422(04)00929-9.
5
A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer's disease.
J Am Geriatr Soc. 2008 Apr;56(4):772-4. doi: 10.1111/j.1532-5415.2008.01620.x.
6
Intravenous immunoglobulins: a treatment for Alzheimer's disease?静脉注射免疫球蛋白：治疗阿尔茨海默病的方法？
J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1374-5. doi: 10.1136/jnnp.2004.043141.
7
Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?是否应该考虑研发针对阿尔茨海默病的静脉注射免疫球蛋白？
J Neuroinflammation. 2014 Dec 5;11:198. doi: 10.1186/s12974-014-0198-z.
8
New Alzheimer's clinical trials to be undertaken by NIA nationwide consortium.
Am J Alzheimers Dis Other Demen. 2006;21(6):460-1.
9
Use of immunoglobulin (Ig) in peripheral neuropathies. Impact of Ig on remission rates: comparison of intravenous immunoglobulin and subcutaneous immunoglobulin.免疫球蛋白（Ig）在外周神经病变中的应用。Ig对缓解率的影响：静脉注射免疫球蛋白与皮下注射免疫球蛋白的比较。
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):25-6. doi: 10.1111/cei.12499.
10
Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.静脉注射免疫球蛋白G治疗自身免疫性大疱性疾病。
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):118-9. doi: 10.1111/cei.12535.
引用本文的文献
1
Immune cells in Alzheimer's disease: insights into pathogenesis and potential therapeutic targets.阿尔茨海默病中的免疫细胞：对发病机制和潜在治疗靶点的见解
Med Rev (2021). 2024 Dec 23;5(3):179-202. doi: 10.1515/mr-2024-0064. eCollection 2025 Jun.
2
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.阿尔茨海默病的药物治疗：系统评价综述。
Eur J Clin Pharmacol. 2022 Oct;78(10):1567-1587. doi: 10.1007/s00228-022-03363-6. Epub 2022 Jul 26.
3
Decreased immunoglobulin G in brain regions of elder female APOE4-TR mice accompany with Aβ accumulation.老年雌性APOE4转基因小鼠脑区中免疫球蛋白G减少，并伴有β淀粉样蛋白（Aβ）积累。
Immun Ageing. 2019 Jan 25;16:2. doi: 10.1186/s12979-018-0142-7. eCollection 2019.
4
Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection.阿昔洛韦和静脉注射免疫球蛋白对单纯疱疹病毒1型中枢神经系统感染后行为结果的影响。
Behav Neurol. 2017;2017:5238402. doi: 10.1155/2017/5238402. Epub 2017 Nov 19.
5
Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease.在一项针对阿尔茨海默病的长期、安慰剂对照研究中，证明静脉注射免疫球蛋白在老年患者中的安全性。
Alzheimers Dement (N Y). 2016 Jun 21;2(2):131-139. doi: 10.1016/j.trci.2016.06.003. eCollection 2016 Jun.
6
Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease.为BAN2401（一种用于治疗阿尔茨海默病的潜在疾病修饰单克隆抗体）设计贝叶斯适应性2期概念验证试验。
Alzheimers Dement (N Y). 2016 Feb 4;2(1):1-12. doi: 10.1016/j.trci.2016.01.001. eCollection 2016 Jan.
7
Importance of neonatal immunoglobulin transfer for hippocampal development and behaviour in the newborn pig.新生仔猪海马发育和行为中新生儿免疫球蛋白转移的重要性。
PLoS One. 2017 Jun 28;12(6):e0180002. doi: 10.1371/journal.pone.0180002. eCollection 2017.
8
The antigen-binding fragment of human gamma immunoglobulin prevents amyloid β-peptide folding into β-sheet to form oligomers.人γ免疫球蛋白的抗原结合片段可防止淀粉样β肽折叠成β片层以形成寡聚体。
Oncotarget. 2017 Jun 20;8(25):41154-41165. doi: 10.18632/oncotarget.17074.
9
A phase 3 trial of IV immunoglobulin for Alzheimer disease.静脉注射免疫球蛋白治疗阿尔茨海默病的3期试验。
Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5.
10
Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis.静脉注射免疫球蛋白的神经保护作用是通过抑制脓毒症大鼠模型中的补体激活和细胞凋亡来介导的。
Intensive Care Med Exp. 2017 Dec;5(1):1. doi: 10.1186/s40635-016-0114-1. Epub 2017 Jan 5.
本文引用的文献
1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.两项评估 bapineuzumab 治疗轻度至中度阿尔茨海默病的 3 期临床试验。
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
2
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.用于轻中度阿尔茨海默病的 solanezumab 的 3 期临床试验。
N Engl J Med. 2014 Jan 23;370(4):311-21. doi: 10.1056/NEJMoa1312889.
3
Is there a causal link between inflammation and dementia?炎症与痴呆之间是否存在因果关系？
Biomed Res Int. 2013;2013:316495. doi: 10.1155/2013/316495. Epub 2013 Jun 6.
4
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.静脉注射免疫球蛋白治疗轻中度阿尔茨海默病的 2 期随机、双盲、安慰剂对照、剂量探索试验。
Lancet Neurol. 2013 Mar;12(3):233-43. doi: 10.1016/S1474-4422(13)70014-0. Epub 2013 Jan 31.
5
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease.人血免疫球蛋白对阿尔茨海默病小鼠模型淀粉样蛋白病理和神经炎症的影响。
J Neuroinflammation. 2012 May 29;9:105. doi: 10.1186/1742-2094-9-105.
6
Intravenous immunoglobulin: exploiting the potential of natural antibodies.静脉注射用免疫球蛋白：开发天然抗体的潜力。
Autoimmun Rev. 2012 Sep;11(11):792-4. doi: 10.1016/j.autrev.2012.02.006. Epub 2012 Feb 12.
7
Measurement of anti-beta amyloid antibodies in human blood.人体血液中抗β淀粉样蛋白抗体的检测
J Neuroimmunol. 2010 Oct 8;227(1-2):167-74. doi: 10.1016/j.jneuroim.2010.06.010. Epub 2010 Jul 31.
8
Anti-amyloidogenic activity of IgGs contained in normal plasma.正常血浆中 IgG 的抗淀粉样变性活性。
J Clin Immunol. 2010 May;30 Suppl 1(Suppl 1):S37-42. doi: 10.1007/s10875-010-9413-6.
9
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.11C-PiB PET 评估 bapineuzumab 治疗阿尔茨海默病患者纤维状淀粉样β负荷的变化：一项 2 期、双盲、安慰剂对照、递增剂量研究。
Lancet Neurol. 2010 Apr;9(4):363-72. doi: 10.1016/S1474-4422(10)70043-0. Epub 2010 Feb 26.
10
IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.静脉注射免疫球蛋白与阿尔茨海默病及相关疾病风险降低有关。
Neurology. 2009 Jul 21;73(3):180-5. doi: 10.1212/WNL.0b013e3181ae7aaf.
Zotero 插件